具有增加的生物利用度的阿伏西地前藥

• 收藏
• 分享

专利权人:

Inc.;Tolero Pharmaceuticals

发明人:

Adam SIDDIQUI-JAIN,David, J. BEARSS

申请号：

HK18111270

公开号：

HK1251941A1

申请日:

2018.09.03

申请国别(地区):

HK

年份:

2019

代理人:

摘要：

Compounds having the following structure (IB') and pharmaceutically acceptable salts thereof are provided. Pharmaceutical compositions comprising the compounds, and methods for use of the compounds for treating diseases associated with overexpression of a cyclin-dependent kinase (CDK) are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/